BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20626558)

  • 1. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice.
    Käenmäki M; Tammimäki A; Myöhänen T; Pakarinen K; Amberg C; Karayiorgou M; Gogos JA; Männistö PT
    J Neurochem; 2010 Sep; 114(6):1745-55. PubMed ID: 20626558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
    Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth.
    El-Khodor BF; Boksa P
    Exp Neurol; 1997 May; 145(1):118-29. PubMed ID: 9184115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.
    Wayment HK; Schenk JO; Sorg BA
    J Neurosci; 2001 Jan; 21(1):35-44. PubMed ID: 11150317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission.
    Napolitano A; Cesura AM; Da Prada M
    J Neural Transm Suppl; 1995; 45():35-45. PubMed ID: 8748607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex.
    Carboni E; Silvagni A; Vacca C; Di Chiara G
    J Neurochem; 2006 Jan; 96(2):473-81. PubMed ID: 16336224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.
    Levy F
    Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
    Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
    J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics.
    Mathews TA; John CE; Lapa GB; Budygin EA; Jones SR
    Synapse; 2006 Sep; 60(4):288-94. PubMed ID: 16786536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
    Nagai T; Kitahara Y; Shiraki A; Hikita T; Taya S; Kaibuchi K; Yamada K
    Neurosci Lett; 2010 Feb; 470(2):134-8. PubMed ID: 20045719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan.
    Tunbridge EM; Weickert CS; Kleinman JE; Herman MM; Chen J; Kolachana BS; Harrison PJ; Weinberger DR
    Cereb Cortex; 2007 May; 17(5):1206-12. PubMed ID: 16835293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress.
    Novick AM; Forster GL; Hassell JE; Davies DR; Scholl JL; Renner KJ; Watt MJ
    Neuropharmacology; 2015 Oct; 97():194-200. PubMed ID: 26056032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects.
    Caldú X; Vendrell P; Bartrés-Faz D; Clemente I; Bargalló N; Jurado MA; Serra-Grabulosa JM; Junqué C
    Neuroimage; 2007 Oct; 37(4):1437-44. PubMed ID: 17689985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.